Cingulate Inc. Expense Breakdown
No Expense Breakdown for CING on this site yet.
- 2026-06-30: Pre Commercialization Costs $1.69M; Legal and Professional Fees $1.04M; Personnel $868.97K; Insurance $149.51K.
- 2025-06-30: Pre Commercialization Costs $98.85K; Legal and Professional Fees $968.99K; Personnel $459.34K; Insurance $174.45K.
Source checked: the stored Expense Breakdown page for CING.
Expenses by product
General and Administrative Expense: each quarter (3 month)
| Quarter end | Pre Commercialization Costs | Legal and Professional Fees | Personnel | Insurance | Other | Occupancy |
|---|
| 2026-06-30 | $1.69M | $1.04M | $868.97K | $149.51K | $136.04K | $46.54K |
|---|
| 2025-06-30 | $98.85K | $968.99K | $459.34K | $174.45K | $159.05K | $88.36K |
|---|
Research and development: each quarter (3 month)
| Quarter end | Personnel | Drug Manufacturing | Clinical Operations |
|---|
| 2026-06-30 | $585.10K | $909.47K | $36.62K |
|---|
| 2025-06-30 | $409.22K | $1.11M | $763.86K |
|---|
Research And Development Expenses: each quarter (3 month)
| Quarter end | Regulatory |
|---|
| 2026-06-30 | -$44.36K |
|---|
| 2025-06-30 | $417.77K |
|---|